Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma.

Kim, Wi Jin; Newman, W Christopher; Amankulor, Nduka M

Kim, Wi Jin; Newman, W Christopher; Amankulor, Nduka M.

Affiliation

Kim WJ; Department of Neurological Surgery University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
Newman WC; Department of Neurological Surgery University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
Amankulor NM; Department of Neurological Surgery University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.

Neurosurgery ; 81(1): N11, 2017 07 01.

Article in En | MEDLINE | ID: mdl-28873996

Subject(s)

Dacarbazine; Glioblastoma; Brain Neoplasms; Dacarbazine/analogs & derivatives; Glioma; Humans; Immunotherapy; Temozolomide

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Dacarbazine Limits: Humans Language: En Journal: Neurosurgery Year: 2017 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google